We are live on
!
Find out more
HM
HealthCor Management Portfolio holdings
AUM
$109M
1-Year Est. Return
10.64%
This Fund
S&P 500
This Quarter
Est. Return
+5.43%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
-$110M
(-5.2%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
5.24%
Top 10 Holdings %
Top 10 Hldgs %
54.66%
Holding
88
New
23
Increased
17
Reduced
12
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$115M |
| 2 |
HCA Healthcare
HCA
|
+$108M |
| 3 |
CVRS
CORINDUS VASCULAR ROBOTICS, INC
CVRS
|
+$85.2M |
| 4 |
AKRX
Akorn Inc
AKRX
|
+$79.8M |
| 5 |
RAD
Rite Aid Corporation
RAD
|
+$56.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$68M |
| 2 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$67M |
| 3 |
Biogen
BIIB
|
+$63.6M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
+$56.2M |
| 5 |
Boston Scientific
BSX
|
+$42.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 76.63% |
| 2 | Miscellaneous | 18.07% |
| 3 | Financials | 5.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OREX
51
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $2.1M | 0.11% |
+42,500
| New | +$2.54M |
|
52
Tenet Healthcare
THC
$21B
| $1.6M | 0.08% |
+27,700
| New | +$1.41M |
|
|
CPRX
53
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.59M | 0.08% |
+385,500
| New | +$1.54M |
|
54
CALL
Agilent Technologies
A
$42.4B
| – | – |
-1,825,000
| Closed | -$75.8M |
|
|
55
Agilent Technologies
A
$42.4B
| – | – |
-525,000
| Closed | -$21.8M |
|
56
Akebia Therapeutics
AKBA
$250M
| – | – |
-594,534
| Closed | -$6.61M |
|
57
Accuray
ARAY
$27.5M
| – | – |
-727,000
| Closed | -$6.76M |
|
|
AVNS
58
DELISTED
Avanos Medical
AVNS
| – | – |
-620,800
| Closed | -$30.5M |
|
|
59
Boston Scientific
BSX
$63.6B
| – | – |
-2,386,700
| Closed | -$42.4M |
|
60
PUT
Cencora
COR
$61.7B
| – | – |
-150,000
| Closed | -$17.1M |
|
61
CVS Health
CVS
$121B
| – | – |
-43,000
| Closed | -$4.44M |
|
62
PUT
Quest Diagnostics
DGX
$27.3B
| – | – |
-75,000
| Closed | -$5.76M |
|
63
CALL
Danaher
DHR
$147B
| – | – |
-773,673
| Closed | -$44.1M |
|
64
CALL
Gilead Sciences
GILD
$181B
| – | – |
-1,000,000
| Closed | -$98.1M |
|
|
65
Gilead Sciences
GILD
$181B
| – | – |
-69,200
| Closed | -$6.79M |
|
66
Illumina
ILMN
$33.6B
| – | – |
-199,535
| Closed | -$36M |
|
|
67
Jazz Pharmaceuticals
JAZZ
$15.6B
| – | – |
-325,000
| Closed | -$56.2M |
|
68
CALL
Merck
MRK
$355B
| – | – |
-524,000
| Closed | -$28.7M |
|
|
69
Merck
MRK
$355B
| – | – |
-753,512
| Closed | -$41.3M |
|
70
CALL
Pfizer
PFE
$157B
| – | – |
-2,108,000
| Closed | -$69.6M |
|
|
71
Pfizer
PFE
$157B
| – | – |
-973,053
| Closed | -$32.1M |
|
|
72
PUT
Tenet Healthcare
THC
$21B
| – | – |
-220,000
| Closed | -$10.9M |
|
73
UnitedHealth
UNH
$337B
| – | – |
-41,300
| Closed | -$4.88M |
|
|
74
CALL
Viatris
VTRS
$19.1B
| – | – |
-800,000
| Closed | -$47.5M |
|
|
75
Viatris
VTRS
$19.1B
| – | – |
-1,146,400
| Closed | -$68M |
|
Similar funds
IA
EPC
TCMV
SI
HCWM
PC
RF
AWM
HealthCor Management's Q2 2015 Portfolio in Review
As of Q2 2015, HealthCor Management held 88 positions worth $1.99B, down 5.2% from $2.1B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
HealthCor Management deployed $104M of net new capital in Q2 2015, opening 23 new positions and adding to 17 existing holdings. Its largest new stake was HCA Healthcare: 1,350,000 shares worth $122M.
By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 68% a quarter earlier, followed by Miscellaneous and Financials.
On the sell side, the largest reduction was Teva Pharmaceutical Industries Limited, an estimated $67M trimmed.
- HealthCor Management's largest Q2 2015 buy was HCA Healthcare: 1,350,000 shares worth $122M.
- HealthCor Management added most to Edwards Lifesciences in Q2 2015, an estimated $115M increase.
- HealthCor Management's biggest Q2 2015 reduction was Teva Pharmaceutical Industries Limited, cutting an estimated $67M.
- HealthCor Management fully exited Viatris in Q2 2015, selling an estimated $68M.
- HealthCor Management's ten largest holdings make up 55% of its $1.99B portfolio in Q2 2015.
- HealthCor Management opened 23 new positions and closed 35 in Q2 2015.
- HealthCor Management's portfolio value fell 5.2% quarter-over-quarter to $1.99B.
Based on HealthCor Management's 13F filing for Q2 2015, filed 14 Aug 2015.